David Hoagland

David Hoagland is an accomplished executive with extensive experience in operations and business development within the medical technology sector. Currently serving as the Chief Operating Officer and Senior Vice President at Blackrock Neurotech since 2021, Hoagland launched a startup business unit focused on neuromodulation therapies, managing a P&L with a $25M budget. Prior roles include Principal Strategy & Business Development at Imricor, where significant contributions led to CE Mark approval and substantial revenue generation, and Principal Product Manager at Starkey Hearing Technologies, where product strategy and market alignment were successfully advanced. Hoagland's career also features leadership positions at Vision Ease, IMRIS, and Medtronic, showcasing a strong track record of driving growth and innovation through strategic marketing and operational excellence. Hoagland holds an MBA from Northwestern University's Kellogg School of Management and a BA from Stanford University.